Te Ahumairangi Investment Management Ltd
Position in BMY — Bristol Myers Squibb Co
CIK 1832237
WELLINGTON, Q2
Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,592,602
+$22,322 QoQ
Shares Held
79,705
+5.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#564
of 2,506 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Te Ahumairangi Investment Management Ltd holds $45,755,777 across 8 Drug Manufacturers - General names. BMY ranks #7 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
31,084 | $7,894,403 | |
| 2 | AZN |
Astrazeneca PLC
|
34,479 | $6,537,907 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,511 | $6,490,663 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
48,936 | $6,182,574 | |
| 5 | PFE |
Pfizer Inc
|
237,946 | $5,729,739 | |
| 6 | ABBV |
AbbVie Inc.
|
21,083 | $5,305,326 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
79,705 | $4,592,602 | |
| 8 | LLY |
ELI LILLY & Co
|
2,520 | $3,022,563 |
All Filings in BMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,592,602 | 79,705 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,570,280 | 75,355 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,186,013 | 77,605 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $4,145,907 | 91,927 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,852,577 | 83,227 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,567,732 | 58,497 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,137,024 | 73,144 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,636,917 | 108,947 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $6,065,747 | 146,057 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,132,168 | 149,957 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $7,476,226 | 145,707 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,367,191 | 161,392 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,227,011 | 159,922 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,757,253 | 140,777 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,987,418 | 124,912 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $7,447,886 | 104,767 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,898,429 | 102,577 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $7,542,319 | 103,277 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,401,910 | 102,677 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,276,576 | 106,077 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,620,325 | 99,077 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,958,020 | 94,377 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,078,830 | 81,877 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,567,781 | 59,177 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||